(Q44596380)

4 December 2017

title

Relationship of clinical symptoms and substance use in schizophrenia patients on conventional versus atypical antipsychotics (English)

1 reference

4 December 2017

0 references

2

1 reference

4 December 2017

author name string

Geraldine Scheller-Gilkey

1

1 reference

4 December 2017

Ilene Cooper

3

1 reference

4 December 2017

Olumuyiwa Gay

4

1 reference

4 December 2017

Kelly A Moynes

5

1 reference

4 December 2017

Andrew H Miller

6

1 reference

4 December 2017

publication date

1 August 2003

1 reference

American Journal of Drug and Alcohol Abuse

4 December 2017

published in

1 reference

4 December 2017

volume

29

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

553-566

1 reference

The course, treatment, and outcome of substance disorder in persons with severe mental illness

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Violence by patients admitted to a private psychiatric hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Suicide and schizophrenia: a nationwide psychological autopsy study on age- and sex-specific clinical characteristics of 92 suicide victims with schizophrenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

A neurobiological basis for substance abuse comorbidity in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Increased Early Life Stress and Depressive Symptoms in Patients With Comorbid Substance Abuse and Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Olanzapine treatment for patients with schizophrenia and substance abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Clozapine for comorbid substance use disorder and schizophrenia: do patients with schizophrenia have a reward-deficiency syndrome that can be ameliorated by clozapine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Effects of clozapine on substance use in patients with schizophrenia and schizoaffective disorder: a retrospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Treatment of the symptoms of schizophrenia: a combined analysis of double-blind studies comparing risperidone with haloperidol and other antipsychotic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

The Fifth Edition of the Addiction Severity Index

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

The positive and negative syndrome scale (PANSS) for schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

A rating scale for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Assessment of a new self-rating scale for post-traumatic stress disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Determinants of medication compliance in schizophrenia: empirical and clinical findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Compliance with antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Relapse in schizophrenia: is there a relationship to substance abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Subjective response to neuroleptics in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

Measurement of Depression and Negative Symptoms in Schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1081%2FADA-120023458

21 January 2018

Identifiers

DOI

10.1081/ADA-120023458

1 reference

4 December 2017

1 reference